Tear Trough Treatment: What Rancho Cordova Residents Should Know

The tear trough is the anatomical groove that runs from the inner corner of your eye down along the nose toward the cheek. When this area loses volume — which naturally occurs with aging — it creates a shadow that makes you look exhausted, even when you are well-rested. Tear trough filler addresses this specific volume deficit by adding a small amount of soft hyaluronic acid filler directly into the groove. The result is a smoother transition from lower eyelid to cheek, eliminating the shadow that creates the appearance of dark circles. For Rancho Cordova residents dealing with perpetual tired eyes despite good sleep, this treatment can be genuinely transformative.

The tear trough area is treated with a very soft filler and requires precise technique. Treatment takes 20–30 minutes and involves tiny amounts of product — typically 0.5–1 syringe total for both eyes. Mild swelling is expected for 3–5 days after treatment. The under-eye area is more prone to swelling than other facial regions, so plan accordingly. Sleeping with your head elevated for the first 2 nights helps minimize swelling. Final results are visible once swelling fully resolves, typically by 2 weeks. The improvement in brightness and youthfulness is remarkable — most patients wish they had done it sooner.

Under-eye filler carries slightly higher risk than other facial areas due to the thin skin and complex vascular anatomy. Potential complications include visible lumps, the Tyndall effect (bluish discoloration from superficially placed filler), and prolonged swelling. These risks are minimized by choosing an experienced injector who uses appropriate products and technique. Amy Mason RN uses conservative volumes and deep placement to ensure smooth, natural results. If you are a first-time filler patient, your injector may recommend starting with cheek filler before tear trough treatment. Lifting the mid-face often improves the under-eye area significantly, potentially reducing or eliminating the need for direct tear trough injection.